Unexpected news in renal fibrosis

Journal of Clinical Investigation

Volumn 110, Issue 12, 2002, Pages 1763-1764

  Oliver, Juan A ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

BONE MARROW CELL; HORMONAL REGULATION; HUMAN; KIDNEY FIBROSIS; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0036950663     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17399     Document Type: Note

References (25)

1. Anderson, S., et al. 1985. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 76:612-619.
2. Taal, M.W., and Brenner, B.M. 2000. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int. 57:1803-1817.
3. Border, W.A., et al. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 346:371-374.
4. Yamamoto, T., et al. 1994. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 45:916-927.
5. Iwano, M., et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350. doi:10.1172/JCI200215518.
6. Barasch, J., et al. 1999. Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell. 99:377-386.
7. Holdsworth, S.R., Neale, T.J., and Wilson, C.B. 1981. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J. Clin. Invest. 68:686-698.
8. Tesch, G.H., et al. 1999. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J. Clin. Invest. 103:73-80.
9. Ophascharoensuk, V., et al. 1999. Obstructive uropathy in the mouse: Role ofosteopontin in interstitial fibrosis and apoptosis. Kidney Int. 56:571-580.
10. Lange-Sperandio, B., et al. 2002. Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int. 61:516-524.
11. Nishida, M., et al. 2002. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J. Clin. Invest. 110:1859-1868. doi:10.1172/JCI200215045.
12. Satoh, M., et al. 2001. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. 12:317-325.
13. Fern, R.J., et al. 1999. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J. Clin. Invest. 103:39-46.
14. Weinstock, J.V., and Kassab, J.T. 1984. Angiotensin II stimulation of granuloma macrophage phagocytosis and actin polymerization in murine schistosomiasis mansoni. Cell. Immunol. 89:46-54.
15. Scheidegger, K.J., Butler, S., and Witztum, J.L. 1997. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway. J. Biol. Chem. 272:21609-21665.
16. Chen, Q., DeFrances, M.C., and Zarnegar, R. 1996. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ. 7:821-832.
17. Mizuno, S., et al. 1998. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101:1827-1834.
18. Yang, J., and Liu, Y. 2002. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nepbrol. 13:96-107.
19. Oliver, J.A., Goldberg, M.R., and Al-Awqati, Q. 1997. Endothelial cell targeting during renal development: Use of monoclonal antibodies. Am. J. Physiol. 272:F153-F159.
20. Sasaki, K., et al. 2002. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest. 109:603-611. doi:10.1172/JCI200213055.
21. Petersen, B.E., et al. 1999. Bone marrow as a potential source of hepatic oval cells. Science. 284:1168-1170.
22. Gussoni, E., et al. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 401:390-394.
23. Wagers, A.J., et al. 2002. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2256-2259.
24. Pittenger, M.F., et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science. 284:143-147.
25. Ito, T., et al. 2001. Application of bone marrow-derived stem cells in experimental nephrology. Exp. Nephrol. 9:444-450.